Chronic kidney disease: risk factors for development and progression


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Risk factors and mechanisms of development and progression of chronic kidney disease are reviewed.

Full Text

Restricted Access

References

  1. Majunath G., Tighionart H., Ibrahim H. et al. Level of kidney function as a risk factors for atherosclerotic cardiovascular outcomes in the community // J Am Coll Cardiol — 2003; 41: 47-55.
  2. Mann J.F.E. Cardiovascular risk in patients with mild renal insufficiency: implication for the use of ACE inhibitors // La Presse Medicale. — 2005; 34(18): 1303—1308.
  3. Nitsch D., Dietrich D.F, von Eckardstein A. et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study //Nephrol Dial Transplant. — 2006; 21(4): 935—944.
  4. Levey A.S., de Jong P.E., Coresh J. et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report //Kidney Int. — 2011; 80(1): 17—28.
  5. Forman J.P., Brenner B.M. «Hypertension» and «microalbuminuria»: The bell tolls for thee // Kidney Int. — 2006; 69: 22—28.
  6. Schmieder R.E., Schrader J., Zidek W. et al. Low-grade albuminuria and cardiovascular risk: what is the evidence?// Clin. Res. Cardiol. — 2007; 96(5): 247—257.
  7. Klausen K.P., Scharling H., Jensen G. et al. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. // Hypertension. — 2005;46(1): 33—37.
  8. Смирнова А.В., Каюков И.Г., Добронравов В.А. Концепция факторов риска в нефрологии: Вопросы профилактики и лечения хронической болезни почек // Нефрология. — 2008; 12(1): 7—13.
  9. Guseppe D. Amiko. Tubulointerstitium as predictor of progression of glomerular diseases // Nefron. — 1999; 83(4):289—295.
  10. Hruby Z., Smolska D., Filipowski H. et al. The importance of tubulointerstitial injury in the early of primary glomerular disease // J Intern Med. — 1998; 243 (3): 215—222.
  11. Чеботарева Н.В., Бобкова И.Н., Козловская Л.В. Молекулярные механизмы интерстициального фиброза при прогрессирующих заболеваниях почек // Нефрология и диализ. — 2006; 1: 26—35.
  12. Risdon R.A., Sloper J.C., Wardener H.E. Relationship between renal function and histologic changes in renal-biopsy specimens from patients with persistents glomerular nephritis // Lancet. — 1968; 2: 363—370.
  13. Schainuk L., Striker G., Cutler R. et al. Structural-functional correlations in renal disease // Hum Pathol. — 1970; 1: 631—641.
  14. Marcussen N. Atubular glomeruli in cisplatin-induced chronic interstitial nephropathy //APMIS. — 1990; 98: 1087—1097.
  15. Marcussen N. Tubulointerstitial damage leads to atubular glomeruli: significance and possible role in progression // Nephrol Dial Transplant. — 2000; 15(Supple 6): 74—75.
  16. Becker G.J., Hewitson T.D. The role of tubulointerstitial injury in chronic renal failure // Curr Opin Nephrol Hypertens. — 2000; 9: 133—138.
  17. Mackensen-Haen S., Bohie A., Christensen J. et al. The consequencesfor renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases // Clin Nephrol. —1992. Vol. 37. 70—77.
  18. Mori Y., Kishimoto N., Yamahara H. et al. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis // Clin Exp Nephrol. — 2005. Vol. 9. № 1. 79—84.
  19. Kriz W., Hartmann I., Hosser H. et al. Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis // J Am Soc Nephrol. — 2001; 12: 496—506.
  20. Тареева И.Е., Бобкова И.Н., Козловская Л.В. и др. Механизмы прогрессирования гломерулонефрита. Под ред. И.Е. Тареевой // Нефрология. Руководство для врачей. — М.: Медицина. 2000. 224—239.
  21. Abbate M., Zoja C., Corna D. et al. In progressive nephropathies overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation // J Am Soc Nephrol. — 1998; 9: 1213—1224.
  22. Muller G.A., Marcovic-Lipkovski J., Frank J. The role of interstitial cells in the progression of renal diseases // J Am Soc Nephrol. — 1992; 2: 198.
  23. Segerer S., Nelson P., Schlondorff D. Chemokines, Chemokine Receptors and renal disease: from basic science to pathophysiologic and therapeutic studies // J Am Soc Nephrol. — 2000; 11:152—176.
  24. Burton C.Y., Walls Y. Interstitial inflammation and scarring: massages from the proximal tubular cell // Nefrol Dial Transplant. — 1996; 11: 1505—1508.
  25. Idasiak Piecbocka I., Krzymanski M. The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis //Przegl Lek. — 1996; 53(5): 443—453.
  26. Viedt C., Orth S. Monocyte chemoattractantprotein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? // Nephrol Dial Transplant. — 2002; 17: 2043—2047.
  27. Baricos W.H., Cortez S.L., Deboisblanc M. et al. Transforming growth factor p is a potent inhibitor of extracellular matrix degrada tion by cultured human mesangial cells // J Am Soc Nephrol. — 1999; 10: 790—795.
  28. Бобкова И.Н., Чеботарева Н.В., Козловская Л.В. и др. Определение экскреции с мочой моноцитарного хемотаксического протеина-1 (МСР-
  29. и трансформирующего фактора роста-1 (TGF-1) — неинвазивный метод оценки тубулоинтерстициального фиброза при хроническом гломерулонефрите// Нефрология. — 2006; 10(4): 49—55.
  30. Арзиманова Н.А., Марасаев В.В., Абиссова Т.О. Иммуно-морфологические особенности гломерулярного и тубулоинтерстициального поражения почек у больных системной красной волчанкой // Научно-практическая ревматология. — 2009; 2:10—17.
  31. Нагорнова К.А., Бугрова О.В., Овчинникова Н.А. и др. Прогностическое значение оценки профиброгенных цитокинов и коллагена IV типа у больных системной красной волчанкой // Сибирский медицинский журнал. — 2011; 5: 77—80.
  32. Tucci M., Barnes E.V., Sobel E.S. et al. Strong Association of a Functional Polymorphism in the Monocyte Chemoattractant Protein 1 Promoter Gene With Lupus Nephritis// Arthritis Rheum. — 2004. Vol. 50. № 6. 1842—1849.
  33. Chan R.W.-Y., Lai F.M.-M., Li E.K.-M. et al. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis // Arthritis Rheum. — 2004. № 50. 2882—2890.
  34. Фомин В.В. Ишемическая болезнь почек: клиническая картина, патогенез, тактика ведения: автореф. дисс. докт. мед. наук. — М., 2008.
  35. Мухин Н.А., Козловская Л.В., Кутырина И.М. и др. Ишемическая болезнь почек// Тер. архив. — 2003; 6: 5—11.
  36. Eddy A.A. Proteinuria and interstitial injury// Nephrol Dial Transplant. — 2004; 19: 277—281.
  37. Burton C. Harris K.P.G. The role of proteinuria in the progression of chronic renal failure // Am J Kidney Dis. — 1996; 27: 765—775.
  38. Meyer T.W. Tubular injury in glomerular disease // Kidney Int. — 2003; 63: 774—787.
  39. Benigni A. Tubulointerstitial disease mediators of injury: the role of endothelin // Nephrol Dial Transplant. — 2000; 15(6): 50—52.
  40. Mobamed R. Daba, C. van Kooten. Is the proximal tubular cell a proinflammatory cell?// Nefrol Dial Transplant. — 2000; 15 (Suppl. 6): 41—43.
  41. Evan A.P., Tanner G.A. Proximal tubule morphology after single nephron obstruction in the rat kidney // Kidney Int. — 1986; 30: 818—827.
  42. Bertani T., Cutillo F., Zoja C. et al. Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy // Kidney Int. — 1986; 30: 488—496.
  43. Eddy A.A., McCulloch L., Adams J. et al. Interstitial nephritis induced by protein-overload proteinuria// Am J Pathol. — 1989; 135: 719—733.
  44. Eddy A.A. Interstitial nephritis induced by heterologous protein-overload proteinuria // Am J Pathol. — 1989; 135: 719—733.
  45. Eddy A.A., Giachelli C.M. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria // Kidney Int. — 1995; 47: 1546—1557.
  46. Schreiner G.F. Renal toxicity of albumin and other lipoproteins // Curr Opin Nephrol Hypertens. — 1995; 151: 369—373.
  47. Tang S., Lai K.N., Chan T.M. et al. Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells// Am J Kidney Dis. — 2001; 37: 94—103.
  48. Kikuchi H., Kawachi H., Ito Y. et al. Severe proteinuria, sustained for 6 months, induces tubular epithelial cell injury and cell infiltration in rats but not progressive interstitial fibrosis //Nephrol. Dial. Transplant. — 2000; 15(6): 799—810.
  49. Kuusniemi A.M., Lapatto R., Holmberg C. et al. Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but not tubular phenotypic change// Kidney Int. — 2005; 68(1): 121—132.
  50. White K.E., Marshall S.M., Bilous R.W. Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy // Nephrol. Dial. Transplant. — 2008; 23(11): 3539—3545.
  51. Fine L.G., Ong A.C.M., Norman J.T. Mechanisms of tubulointerstitial injury in progressive renal diseases// Eur. J. Clin. Invest. — 1993; 23: 259—265.
  52. Mazzali M., Jefferson J.A. Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension // Kidney Int. — 2003; 63: 2088—2093.
  53. Matsumoto M., Tanaka T., Yamamoto T. et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis // J Am Soc Nephrol. — 2004; 15: 1574—1581.
  54. Fliser D., Ritz E. Nephrol Dial Transplant. — 1996; 11 (Suppl. 9): 2—8.
  55. Wolf G., Neilson E.G. Angiotensin II as a renal growth factor // J Am Soc Nephrol. — 1993; 3:1531—1540.
  56. Арутюнов А.Г., Оганезова Л.Г. Тубулоинтерстициальный аппарат почки и его поражение при артериальной гипертензии // Клиническая нефрология. — 2011; 1: 52—57.
  57. Eknoyan G., McDonald M.A., Appel D. et al. Chronic tubulointerstitial nephritis: correlation between structural and functional findings // Kidney Int. — 1990; 38: 736—743.
  58. Muntner P., Coresh J., Smith C. et al. Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study // Kidney Int. — 2000; 58: 293—301.
  59. Schaeffner E.S., Kurth T., Curhan G.C. et al. Cholesterol and the risk of renal dysfunction in apparently healthy men // J. Am. Soc. Nephrol. — 2003; 14: 2084—2091.
  60. Samuelsson O., Mulec H., Knight-Gibson C. et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency// Nephrol. Dial. Transplant. — 1997; 12:1908—1915.
  61. Manttary M., Tiula E., Alikoski T. et al. Effect of hypertension and dyslipidemia on the declain in renal function // Hypertension. — 1995; 26: 670—675.
  62. Hunsicker L.G., Adler S., Caggiula A. et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study // Kidney Int. — 1997; 51:1908—1919.
  63. Attman P.O., Alaupovic P., Tavella M. et al. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure // Nephrol. Dial. Transplant. — 1996; 11: 63—69.
  64. Руденко Т.Е., Кутырина И.М., Швецов М.Ю. Состояние липидного обмена при хронической болезни почек // Клиническая нефрология. — 2012; 2: 14—21.
  65. Vaziri N.D., Sato T., Liang K. Molecular mechanism of altered cholesterol metabolism in focal glomerulosclerosis // Kidney Int. — 2003; 63:1756 — 1763.
  66. Vaziri N.D., Liang K. Downregulation of tissue lipoprotein lipase expression in experimental chronic renal failure // Kidney Int. — 1996; 50: 1928—1935.
  67. Vaziri N.D., Liang K., Park J.S. Acquired lecithin: Cholesterol acyltransferase (LCAT) deficiency in nephrotic syndrome//Am J Physiol. — 2001; 49: F823 —F829.
  68. Trevisan R., Dodesini A.R., Lepore G. Lipids and renal disease// J. Am. Soc. — Nephrol. 2006; 17: S145—S147.
  69. Keane W.F., Kasiske B.L., O’Donnel M.P. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis // Am. J. Nephrol. — 1988; 8: 261—271.
  70. Moorhead J.F., Chan M.K., El-Nahas M. et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease // Lancet. — 1982; 2: 1209—1311.
  71. Cases A., Coll E. Dyslipidemia and the progression of renal disease in chronic renal failure patients // Kidney Int. — 2005; Suppl. 99: S87—S93.
  72. Chait A., Heinecke J.W. Lipoprotein modification: Cellular mechanisms // Current Opin Lipidol. — 1994; 5: 363—370.
  73. Scheuer H., Gwinner W., Hohbach J. et al. Oxidant stress in hyperlipidemia-induced renal damage // Am J Physiol Renal Physiol. — 2000; 278: F63 —F74.
  74. Joles J.A., Kunter U., Janssen U. et al. Early mechanisms of renal injure in hypercholesterolemic or hypertrigyceridemic rats // J. Am. Soc. Nephrol. — 2000; 11: 669—683.
  75. Mai M., Geiger H., Hilgers K.F. et al: Early interstitial changes in hypertension-induced renal injury//Hypertension. — 1993; 22: 754—765.
  76. Tylicki L., Manitius J., Rutkowski B. et al. Tubular injury: The first symptom of Hypertensive kidney involvement?//Med Sci Monit. — 2003; 9: CR135— CR41.
  77. Jafar T.H., Stark P.C., Schmid C.H. et al. Progression of chronic kidney disease: the role of blood pressure control proteinuria and angiotensin-converting enzyme inhibition: a patient-level meta-analysis // Ann Intern Med. — 2003; 139: 244—252.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies